CRISPR Therapeutics
CRSP
#3064
Rank
NZ$6.96 B
Marketcap
$81.55
Share price
1.86%
Change (1 day)
-11.45%
Change (1 year)

Market capitalization of CRISPR Therapeutics (CRSP)

Market cap: NZ$6.96 Billion

As of November 2024 CRISPR Therapeutics has a market cap of NZ$6.96 Billion. This makes CRISPR Therapeutics the world's 3064th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CRISPR Therapeutics from 2016 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$6.96 B-11.48%
2023NZ$7.86 B56.85%
2022NZ$5.01 B-40.96%
2021NZ$8.49 B-43.81%
2020NZ$15.11 B174.88%
2019NZ$5.49 B148.89%
2018NZ$2.20 B65.95%
2017NZ$1.33 B14.3%
2016NZ$1.16 B

End of Day market cap according to different sources

On Nov 14th, 2024 the market cap of CRISPR Therapeutics was reported to be:

NZ$6.83 Billion
by Nasdaq info icon info icon
NZ$6.83 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$1.01 B-85.48%๐Ÿ‡บ๐Ÿ‡ธ USA